Physician profile
David A Smiley
NPI 1316974538
$1,337.09
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $956 · 2020: $207 · 2024: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $174.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $271.59 | 2019-2020 | |
| Amgen INC. | $242.63 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $175.74 | 2019 | |
| Edwards Lifesciences Corporation | $174.43 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Novo Nordisk INC | $90.84 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $82.10 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $48.66 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $45.45 | 2019-2020 | |
| Sanofi Pasteur INC. | $42.25 | 2019-2020 | |
| Glaxosmithkline, LLC. | $27.40 | 2019 | |
| Allergan, INC. | $21.25 | 2019 | |
| Pfizer INC. | $20.56 | 2019 | |
| Ethicon US, LLC | $20.40 | 2019 | |
| Lilly USA, LLC | $17.55 | 2019 | |
| Radius Health, INC. | $16.09 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $15.10 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.82 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Smiley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.